- Home
- Automated
- List of product information
- CLAMOVID BID GRANULES 228 MG/5 ML [SIN12233P]
CLAMOVID BID GRANULES 228 MG/5 ML [SIN12233P]
Active ingredients: CLAMOVID BID GRANULES 228 MG/5 ML
Last updated 26 October 2025
On this page
Product Info
CLAMOVID BID GRANULES 228 MG/5 ML
[SIN12233P]
Product information
Active Ingredient and Strength | AMOXYCILLIN TRIHYDRATE - 200 MG/5 ML |
Dosage Form | GRANULE, FOR SUSPENSION |
Manufacturer and Country | BILIM ILAC SANAYI VE TICARET ANONIM SIRKETI - TURKEY |
Registration Number | SIN12233P |
Licence Holder | GOLDPLUS UNIVERSAL PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | J01CR02 |
INDICATIONS
For treatment of acute otitis media, sinusitis, pneumonia, skin and soft tissues infections, urinary tract infections caused by beta-lactamase-producing bacteria.
DOSAGE AND ADMINISTRATION
To reconstitute, fill half of the bottle with water. Replace cap and shake the bottle untill all of the powder is suspended. Allow to stand for 5 minutes. Add more water until the 70ml mark. Shake again.
Table caption
Mild to moderate infections | |
2 to 6 years (13 to 21 kg) | : Oral, 5mL every 12 hours |
7 to 12 years (22 to 40 kg) | : Oral, 10mL every 12 hours |
Severe infections | |
2 to 6 years (13 to 21 kg) | : Oral, 10mL every 12 hours |
Duration of therapy should be appropriate to the indication and should not exceed 14 days without review.
CONTRAINDICATIONS
Contraindicated in patients known to be hypersensitive to penicillin. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins.
Contraindicated in patients with a previous history of penicillin-associated jaundice/hepatic dysfunction.
Contraindicated in patients with infectious mononucleosis.